Mode
Text Size
Log in / Sign up

Type 1 diabetes mellitus

Part of Type 1 Diabetes

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Type 1 diabetes mellitus

350 trials tracked for Type 1 diabetes mellitus: 101 in phase 3 or 4 and 46 with published results. The most-cited published study has 489 citations.

350Trials tracked
101Phase 3 & 4
0Recruiting
46With published results
Phase distribution
Phase 4 25 Phase 3 76 Phase 2 64 Phase 1 39 Other / NA 146
  1. Phase 3 The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus Completed · 489 cited
  2. Phase 3 Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) Completed · 355 cited
  3. Phase 3 Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) Completed · 355 cited
  4. Phase 3 REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL) Completed · 346 cited
  5. Phase 3 The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes Completed · 329 cited
  6. Phase 3 The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes Completed · 249 cited
Show 44 more trials
  1. Phase 3 Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab Completed · 231 cited
  2. Phase 3 Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy Completed · 227 cited
  3. Phase 3 A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes Completed · 207 cited
  4. Phase 3 Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Completed · 202 cited
  5. Phase 3 A Study in Participants With Type I Diabetes Mellitus Completed · 185 cited
  6. Phase 3 A Study in Participants With Type 1 Diabetes Mellitus Completed · 185 cited
  7. Phase 3 Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy Completed · 182 cited
  8. Phase 3 Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes Completed · 176 cited
  9. Phase 3 Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes Completed · 121 cited
  10. Phase 3 Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease Completed · 106 cited
  11. Phase 3 A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6) Completed · 100 cited
  12. Phase 3 Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes Completed · 77 cited
  13. Phase 3 Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes Completed · 77 cited
  14. Phase 3 Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes Completed · 77 cited
  15. Phase 3 Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes Completed · 69 cited
  16. Phase 3 The Bihormonal iLet Bionic Pancreas Feasibility Study Completed · 68 cited
  17. Phase 4 Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study Completed · 67 cited
  18. Phase 3 Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes Completed · 67 cited
  19. Phase 3 Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes Completed · 54 cited
  20. Phase 3 A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects Completed · 52 cited
  21. Phase 3 Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes Completed · 48 cited
  22. Phase 3 FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump Completed · 36 cited
  23. Phase 3 Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Completed · 33 cited
  24. Phase 3 Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics Completed · 32 cited
  25. Phase 4 Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D) Completed · 30 cited
  26. Phase 3 Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus Completed · 27 cited
  27. Phase 4 Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients Completed · 22 cited
  28. Phase 3 G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes Completed · 22 cited
  29. Phase 3 Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics Completed · 22 cited
  30. Phase 3 A Study of LY900014 in Participants With Type 1 Diabetes Completed · 13 cited
  31. Phase 3 A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003) Completed · 9 cited
  32. Phase 3 G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes Completed · 8 cited
  33. Phase 3 Mylan Insulin Aspart Study Completed · 8 cited
  34. Phase 4 Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones. Completed · 6 cited
  35. Phase 3 A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus Completed · 5 cited
  36. Phase 4 Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings Completed · 4 cited
  37. Phase 3 Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Completed · 3 cited
  38. Phase 4 Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency Completed · 2 cited
  39. Phase 3 Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults Completed · 2 cited
  40. Phase 3 A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Completed · 2 cited
  41. Phase 4 Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon Completed
  42. Phase 4 Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus Completed
  43. Phase 4 Sitagliptin Dose Determination Study Completed
  44. Phase 4 Detemir: Role in Type 1 Diabetes Completed

Showing the 50 most-cited and recently-updated of 350 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Type 1 Diabetes

Related studies from across the Type 1 Diabetes family.

Pancreatic tissue engineering faces vascularization hurdle in type 1 diabetes therapy
Diabetes & Endocrinology Sys. Review
Pancreatic tissue engineering faces vascularization hurdle in type 1 diabetes therapy New tissue engineering methods aim to improve pancreatic transplants
This narrative review examines pancreatic tissue engineering for type 1 diabetes, highlighting insufficient vascularization as the dominant …
Current pancreas transplants are limited by a shortage of donors and the need for lifelong drugs. New engineering techniques may offer a dif…
CAR technology for autoimmune disorders, infectious diseases, fibrotic lesions, inflammatory bowel disease, and type 1 diabetes is reviewed
Allergy & Immunology Sys. Review
CAR technology for autoimmune disorders, infectious diseases, fibrotic lesions, inflammatory bowel disease, and type 1 diabetes is reviewed Chimeric antigen receptor technology may help treat autoimmune disorders and other conditions
This narrative review discusses the application of chimeric antigen receptor (CAR) technology across autoimmune disorders, infectious diseas…
A narrative review suggests chimeric antigen receptor technology could be useful for treating autoimmune disorders, infectious diseases, and…
scFv-based biologics show potential for immunomodulation in type 1 and type 2 diabetes
Allergy & Immunology Sys. Review
scFv-based biologics show potential for immunomodulation in type 1 and type 2 diabetes Review explores scFv biologics for Type 1 and Type 2 diabetes care
This narrative review explores the potential of single-chain variable fragment (scFv)-based biologics for treating type 1 and type 2 diabete…
This review looks at scFv-based biologics for diabetes. It discusses how these treatments might help with immune control and blood sugar bal…
Meta-analysis finds no link between early-life antibiotics and type 1 diabetes risk
Diabetes & Endocrinology Meta-analysis
Meta-analysis finds no link between early-life antibiotics and type 1 diabetes risk Antibiotics in Pregnancy Don’t Raise Child’s Diabetes Risk, Study Finds
This meta-analysis of early-life antibiotic exposure found no significant association with type 1 diabetes incidence in the general populati…
This large review offers reassurance that standard antibiotic use during pregnancy and infancy is safe regarding type 1 diabetes risk, with …
Early-life antibiotic exposure linked to modest increased risk of childhood type 1 diabetes
Diabetes & Endocrinology Meta-analysis
Early-life antibiotic exposure linked to modest increased risk of childhood type 1 diabetes Meta-analysis links early-life antibiotic use to higher childhood type 1 diabetes risk
This meta-analysis of early-life antibiotic use found a modest increased risk of childhood type 1 diabetes. Prenatal exposure showed a poole…
A large meta-analysis suggests early antibiotic exposure may slightly raise childhood type 1 diabetes risk, though causality remains unclear…
Women with Type 1 Diabetes have a 2.10 times higher risk of female sexual dysfunction compared to age-matched controls
Diabetes & Endocrinology Meta-analysis
Women with Type 1 Diabetes have a 2.10 times higher risk of female sexual dysfunction compared to age-matched controls Women with Type 1 Diabetes face a higher risk of sexual dysfunction than controls
This systematic review and meta-analysis evaluated the prevalence and risk of female sexual dysfunction in women with Type 1 Diabetes. The p…
A large review found that women with Type 1 Diabetes are significantly more likely to experience sexual dysfunction compared to healthy wome…
Systematic review and meta-analysis on probiotics for glycemic control in pediatric type 1 diabetes
Diabetes & Endocrinology Meta-analysis
Systematic review and meta-analysis on probiotics for glycemic control in pediatric type 1 diabetes New review shows probiotics may help lower blood sugar levels in kids with type 1 diabetes
This systematic review and meta-analysis synthesized evidence on oral probiotics, prebiotics, or synbiotics in children and adolescents with…
A study of 808 children found that taking probiotics helped lower blood sugar and A1C levels. More research is needed to find the best type …
Case report of high-dose ceftazidime in an 84-year-old man with skull base osteomyelitis and type 1 diabetes
Rheumatology Sys. Review
Case report of high-dose ceftazidime in an 84-year-old man with skull base osteomyelitis and type 1 diabetes High-dose antibiotic shows partial skull base infection resolution
This case report describes an 84-year-old man with type 1 diabetes, vascular comorbidity, and advanced frailty treated for skull base osteom…
An 84-year-old man with diabetes and a rare skull infection saw some improvement with a long antibiotic course, but his condition remained c…
Systematic review finds no difference in hypoglycemia or ketoacidosis between insulin types
Diabetes & Endocrinology Meta-analysis
Systematic review finds no difference in hypoglycemia or ketoacidosis between insulin types Children on insulin may not need newer expensive versions
A meta-analysis of 1,107 children with type 1 diabetes found no significant difference in severe hypoglycemia, ketoacidosis, or serious adve…
A major review finds older human insulin works as safely as newer analogues for children with type 1 diabetes, which could ease costs for fa…
Semaglutide reduces insulin dose in adults with type 1 diabetes and obesity
Nutrition & Obesity Medicine RCT
Semaglutide reduces insulin dose in adults with type 1 diabetes and obesity Semaglutide Cuts Insulin Needs By Half In Type 1 Diabetes
A post hoc analysis of an RCT found that semaglutide 1 mg/week significantly reduced total daily insulin dose by 22.6% over 26 weeks in adul…
Semaglutide reduces insulin needs quickly in type 1 diabetes patients, offering a new hope for better blood sugar control and weight managem…
Umbrella review identifies risk factors and protective factors for male infertility and semen quality
Nutrition & Obesity Medicine Meta-analysis
Umbrella review identifies risk factors and protective factors for male infertility and semen quality New study lists many things that hurt male fertility and health
This umbrella review of 43 studies synthesizes evidence on risk factors for male infertility and abnormal semen parameters.
A new review shows that obesity, smoking, and certain illnesses can hurt sperm, but healthy habits might fix the problem.
Narrative review of transposable element methylation in autoimmune diseases
Diabetes & Endocrinology Sys. Review
Narrative review of transposable element methylation in autoimmune diseases Genetic elements may link autoimmune diseases to inflammation
This narrative review examines the role of transposable element (TE) methylation and expression in Type 1 diabetes, systemic lupus erythemat…
Changes in certain genetic elements could explain how the body triggers inflammation in diseases like lupus and rheumatoid arthritis.

Questions about Type 1 diabetes mellitus

Can cervical cancer treatment cause new Type 1 diabetes and diabetic ketoacidosis?

Yes, certain cervical cancer treatments, especially immune checkpoint inhibitors like cadonilimab, can trigger new-onset type 1 diabetes and diabetic ketoacidosis, though this is a rare but serious side effect.

Full answer →
Can integrative therapies help improve blood sugar control in Type 1 diabetes?

Integrative therapies like yoga and naturopathy may offer modest adjunctive benefits for blood sugar control in Type 1 diabetes, but evidence is limited and they should complement, not replace, standard insulin therapy.

Full answer →